Page 398 - Multidisipliner Covid 19
P. 398

BÖLÜM  23






             CoV-2  J Invest Dermatol . 2020 May 23; S0022-202X(20) 31602-X.doi:
             10.1016/j. jid. 2020.05.087. Online ahead of print.
          8. Lan J, Song Z, BS,Xiaoping Miao X et al.  Skin damage among health
             care workers managing coronavirus disease-2019. J Am Acad Dermatol
             2020 May; 82 (5): 1215–1216.
          9. Lin P, Zhu S, Huang Y, et al. Adverse skin reactions among healthcare
             workers during the coronavirus disease 2019 outbreak: a survey in
             Wuhan and its surrounding regions. Br J Dermatol 2020. April
             doi.org/10.1111/bjd.19089
          10. Jiang Q, Song S, Zhou J, et al. The Prevalence, Characteristics, and
             Prevention Status of Skin Injury Caused by Personal Protective
             Equipment Among Medical Staff in Fighting COVID-19: A Multicenter,
             Cross-Sectional Study. Adv Wound Care (New Rochelle) 2020.
          11. Campanati A, Brisigotti V, Diotallevi F, D'Agostino GM, Paolinelli M,
             Radi G, Rizzetto G, Sapigni C, Tagliati C, Offidani A.Active implications
             for dermatologists in "SARS-CoV-2 era": Personal experience and
             review of literature. J Eur Acad Dermatol Venereol. 2020 May 19. doi:
             10.1111/jdv.16646. [Epub ahead of print]. Review / commentary.
             https://doi.org/10.1111/jdv.16646
          12. Madigan LM, Micheletti RG, Shinkai K. How dermatologists can learn
             and contribute at the leading edge of the COVID-19 global pandemic.
             JAMA Dermatol. 2020 Apr 30. doi: 10.1001/jamadermatol. 2020.1438.
             [Epub ahead of print] No abstract available. Editorial.
             https://doi.org/10.1001/jamadermatol. 2020.1438
          13. Zheng Y, Lai W. Dermatology staff participate in fight against Covid-
             19 in China. J Eur Acad Dermatol Venereol. 2020 Mar 23.
             doi:10.1111/jdv.16390. [Epub ahead of print].
          14. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus
             disease 2019 in China. N Engl J Med. 2020;382(18):1708_1720
             15. Recalcati S. Cutaneous manifestations in COVID-19: a first perspec-
             tive [published online ahead of print, 2020 Mar 26]. J Eur Acad
             Dermatol Venereol. 2020;10.1111/jdv.16387. doi:10.1111/jdv.16387
          16. Galván Casas C, Català A, Carretero Hernández G, et al. Classification
             of the cutaneous manifestations of COVID-19: a rapid prospective
             nationwide consensus study in Spain with 375 cases [published online
             ahead of print, 2020 Apr 29]. Br J Dermatol. 2020;10.1111/bjd.19163.
             doi:10.1111/bjd.19163




                                                                        397
   393   394   395   396   397   398   399   400   401   402   403